Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 low risk children who had been vaccinated starting at birth with hepatitis B vaccine.

Anti-HBs is a neutralizing antibody and its presence suggests the recovery from hepatitis B and confers a long-term protective immunity against HBV infection. In addition, it is the only ...

All students must have a series of three Hepatitis B vaccinations (0, 1, and 6 months), and a post-vaccine surface antibody titer (to demonstrate immunity). The earliest the antibody titer can be ...

Brelovitug (BJT-778) is a fully human immunoglobulin G1 monoclonal antibody designed to target hepatitis B surface antigen and neutralize and remove HBV and HDV virions. The company reports that ...

a monoclonal antibody. Notably, those who received nivolumab exhibited higher rates of hepatitis B surface antigen (HBsAg) loss compared to other groups. This is seen as a significant step forward ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus ... either positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).

B, and C. Hepatitis A can make you feel like you have the flu. The first symptoms show up 15-50 days after contact with the virus. An anti-smooth muscle antibody test is a blood test that detects ...

Hepatitis B surface antigen vaccine (recombinant ... to elicit antibodies to hepatitis B virus as measured by ELISA. Antibody concentrations ≥10mIU/mL against HBsAg are recognized as conferring ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human immunoglobulin G1 (IgG1) monoclonal antibody, brelovitug, to treat ...